The biopharmaceutical industry contemplates product innovation within the changing landscape of healthcare.
Michael N. Abrams
Advertisement
Articles by Michael N. Abrams
A look back at the history of orphan drugs in the industry.
Rather than seeking a single indication for one large group, the orphan-drug approach segments the market for a drug more minutely.
Advertisement
Latest Updated Articles
The Affordable Care Act's Impact on Innovation in BiopharmaPublished: February 1st 2014 | Updated:
- The Growing Orphan-Drug Paradigm
Published: April 1st 2012 | Updated:
A 25-Year Retrospective on Orphan DrugsPublished: August 1st 2012 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
New Cellevate Nanofiber Microcarriers Aim to Transform Vaccine Manufacturing Processes
2
In KPMG's CEO Outlook, AI, Regulatory Demands, and Supply Chain Risk Rank High
3
Overcoming Funding Challenges and Maintaining Optimism in CGTs (Part 1)
4
Rentschler’s Time Capsule and How it Symbolizes European Biotech Progress
5
